[1]
|
韩苏军, 王栋, 李长岭, 邢念增, 张思维. 1998-2008 年中国肾癌发病趋势分析[J]. 癌症进展, 2018, 16(10): 1234-1237.
|
[2]
|
高五岳, 刘建民. 肾癌生物免疫治疗进展[J]. 海南医学杂志, 2016, 27(8): 1298.
|
[3]
|
刘佳, 周公哺, 崔龙. 肾癌的免疫治疗研究进展[J]. 中国科技信息, 2011(10): 218-218.
|
[4]
|
高燕华, 高春芳, 王道元, 等. 肾癌患者手术及免疫治疗前后的血清蛋白指纹图谱的研究[J]. 临床泌尿外科杂志, 2014, 29(3): 191-195.
|
[5]
|
曹达龙, 叶定伟. 转移性肾癌中免疫治疗的研究进展[J]. 中国癌症杂志, 2017, 27(10): 829-832.
|
[6]
|
Bersanelli, M. and Buti, S. (2017) From Targeting the Tumor to Targeting the Immune System: Transversal Challenges in Oncology with the Inhibition of the PD-1/PD-L1 Axis. World Journal of Clinical Oncology, 8, 37-53.
https://doi.org/10.5306/wjco.v8.i1.37
|
[7]
|
Chen, D.S. and Mellman, I. (2013) Oncology Meets Immunology: The Cancer-Immunity Cycle. Immunity, 39, 1-10.
https://doi.org/10.1016/j.immuni.2013.07.012
|
[8]
|
Wang, J., Nakamoto, T., Kasaoka, Y., Usui, T. and Hamada, H. (2000) Anti-Tumor Effect of Murine Renal Cell Carcinoma Cells Genetically Modified to Express B7-1 Combined with Cytokine Secreting Fibroblasts. Hiroshima Journal of Medical Sciences, 49, 73-82.
|
[9]
|
Liang, F. and Fan, D.P. (2017) Emodin Suppresses Tumor Growth through Downregulation of CD155 [C]//中国免疫学会. 第十二届全国免疫学学术大会摘要汇编. 中国免疫学会, 2017.
|
[10]
|
邓虎平. 人可溶型CD155分子产生机制的研究[J]. 中华微生物和免疫学杂志, 2007, 20(9): 112-119.
|
[11]
|
Mahnke, K. and Enk, A.H. (2016) TIGIT-CD155 Interactions in Melanoma: A Novel Co-Inhibitory Pathway with Potential for Clinical Intervention. Journal of Investigative Dermatology, 136, 9-11.
https://doi.org/10.1016/j.jid.2015.10.048
|
[12]
|
张栋梁. CD226/TIGIT-CD155信号调控巨噬细胞极化参与同种异体皮瓣移植排斥反应的机制[C]//中国免疫学会.第十二届全国免疫学学术大会摘要汇编. 中国免疫学会, 2017.
|
[13]
|
庄然. CD226及其配体CDl12/CDl55分子相互作用机制的研究[J]. 中华医学杂志, 2007, 20(3): 11-19.
|
[14]
|
Wang, Y.J., Chen, C., Dong, F., Ma, S.H., Xu, J., Gong, Y.M., Cheng, H., Zhou, Y., Cheng, T. and Hao, S. (2015) NK Cells Play a Significant Role in Immunosurveillance at the Early Stage of MLL-AF9 Acute Myeloid Leukemia via CD226/CD155 Interactions. Science China (Life Sciences), 58, 1288-1298. https://doi.org/10.1007/s11427-015-4968-3
|
[15]
|
王帅威, 罗雪瑞, 李扬扬, 等. T细胞抑制性受体及其免疫调节作用[J]. 科技导报, 2015, 33(18): 84-90.
|
[16]
|
何雨珂. 抑制性受体TIGIT对NK细胞“教育”的调控作用[D]: [博士学位论文]. 合肥市: 中国科学技术大学, 2017.
|
[17]
|
龚玖瑜. 调控NK细胞杀伤肿瘤细胞免疫新分子的发现和机制研究[D]: [博士学位论文]. 中国肿瘤医学杂志, 2012, 26(9): 19-21.
|
[18]
|
尹晓婉, 刘婷婷, 张子宁, 丁海波, 付帅, 赵雯, 唐甜, 王晓楠, 姜拥军. HIV感染者CD4+ T细胞TIGIT受体及其配体CD155表达情况研究[J]. 免疫学杂志, 2017, 33(11): 985-990.
|
[19]
|
He, W., Zhang, H., Han, F., Chen, X., Lin, R., Wang, W., Qiu, H., Zhuang, Z., Liao, Q., Zhang, W., Cai, Q., Cui, Y., Jiang, W., Wang, H. and Ke, Z. (2017) CD155T/TIGIT Signaling Regulates CD8+ T-Cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer. Cancer Research, 77, 6375-6388.
https://doi.org/10.1158/0008-5472.CAN-17-0381
|
[20]
|
Chandramohan, V., Bryant, J.D., Piao, H., Keir, S.T., Lipp, E.S., Lefaivre, M., Perkinson, K., Bigner, D.D., Gromeier, M. and McLendon, R.E. (2017) Validation of an Immuno-histochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas. Archives of Pathology & Laboratory Medicine, 141, 1697-1704.
https://doi.org/10.5858/arpa.2016-0580-OA
|
[21]
|
Huang, D.W., Huang, M., Lin, X.S. and Huang, Q. (2017) CD155 Expression and Its Correlation with Clinicopathologic Characteristics, Angiogenesis, and Prognosis in Human Cholangiocarcinoma. OncoTargets and Therapy, 10, 3817-3825. https://doi.org/10.2147/OTT.S141476
|
[22]
|
Inozume, T., Yaguchi, T., Furuta, J., Harada, K., Kawakami, Y. and Shimada, S. (2016) Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector Phase. Journal of Investigative Dermatology, 136, 255-263. https://doi.org/10.1038/JID.2015.404
|
[23]
|
Nishiwada, S., Sho, M., Yasuda, S., Shimada, K., Yamato, I., Akahori, T., Kinoshita, S., Nagai, M., Konishi, N. and Nakajima, Y. (2015) Clinical Significance of CD155 Expression in Human Pancreatic Cancer. Anticancer Research, 35, 2287-2297.
|
[24]
|
Iwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T. and Minato, N. (2002) Involvement of PD-L1 on Tumor Cells in the Escape from Host Immune System and Tumor Immunotherapy by PD-L1 Blockade. Proceedings of the National Academy of Sciences, 99, 12293-12297. https://doi.org/10.1073/pnas.192461099
|
[25]
|
Dong, H., Strome, S.E., Salomao, D.R., Tamura, H., Hirano, F., Flies, D.B., Roche, P.C., Lu, J., Zhu, G., Tamada, K., Lennon, V.A., Celis, E. and Chen, L. (2002) Tumor-Associated B7-H1 Promotes T-Cell Apoptosis: A Potential Mechanism of Immune Evasion. Nature Medicine, 8, 793-800. https://doi.org/10.1038/nm730
|
[26]
|
Nomi, T., Sho, M., Akahori, T., Hamada, K., Kubo, A., Kanehiro, H., Naka-mura, S., Enomoto, K., Yagita, H., Azuma, M. and Nakajima, Y. (2007) Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer. Clinical Cancer Research, 13, 2151-2157.
https://doi.org/10.1158/1078-0432.CCR-06-2746
|
[27]
|
Cho, Y., Miyamoto, M., Kato, K., Fukunaga, A., Shichi-nohe, T., Kawarada, Y., Hida, Y., Oshikiri, T., Kurokawa, T., Suzuoki, M., Nakakubo, Y., Hiraoka, K., Murakami, S., Shinohara, T., Itoh, T., Okushiba, S., Kondo, S. and Katoh, H. (2003) CD4+ and CD8+ T Cells Cooperate to Improve Prognosis of Patients with Esophageal Squamous Cell Carcinoma. Cancer Research, 63, 1555-1559.
|
[28]
|
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pages, C., Tosolini, M., Camus, M., Berger, A., Wind, P., Zinzindohoue, F., Bruneval, P., Cugnenc, P.H., Trajanoski, Z., Fridman, W.H. and Pages, F. (2006) Type, Density, and Location of Immune Cells within Human Colorectal Tumors Predict Clinical Outcome. Science, 313, 1960-1964. https://doi.org/10.1126/science.1129139
|
[29]
|
Lee, H.E., Chae, S.W., Lee, Y.J., Kim, M.A., Lee, H.S., Lee, B.L. and Kim, W.H. (2008) Prognostic Implications of Type and Density of Tumour-Infiltrating Lymphocytes in Gastric Cancer. British Journal of Cancer, 99, 1704-1711.
https://doi.org/10.1038/sj.bjc.6604738
|
[30]
|
Enomoto, K., Sho, M., Wakatsuki, K., Takayama, T., Matsumoto, S., Nakamura, S., Akahori, T., Tanaka, T., Migita, K., Ito, M. and Nakajima, Y. (2012) Prognostic Importance of Tu-mour-Infiltrating Memory T Cells in Oesophageal Squamous Cell Carcinoma. Clinical & Experimental Immunology, 168, 186-191.
https://doi.org/10.1111/j.1365-2249.2012.04565.x
|
[31]
|
Ino, Y., Yamazaki-Itoh, R., Shimada, K., Iwasaki, M., Kosuge, T., Kanai, Y. and Hiraoka, N. (2013) Immune Cell Infiltration as an Indicator of the Immune Microenvironment of Pancreatic Cancer. British Journal of Cancer, 108, 914-923. https://doi.org/10.1038/bjc.2013.32
|
[32]
|
Hodi, F.S., O’Day, S.J., McDermott, D.F., Weber, R.W., Sosman, J.A., Haanen, J.B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J.C., Akerley, W., van den Eertwegh, A.J., Lutzky, J., Lorigan, P., Vaubel, J.M., Linette, G.P., Hogg, D., Ottensmeier, C.H., Lebbe, C., Peschel, C., Quirt, I., Clark, J.I., Wolchok, J.D., Weber, J.S., Tian, J., Yellin, M.J., Nichol, G.M., Hoos, A. and Urba, W.J. (2010) Improved Survival with Ipilimumab in Patients with Metastatic Melanoma. The New England Journal of Medicine, 363, 711-723. https://doi.org/10.1056/NEJMoa1003466
|
[33]
|
Topalian, S.L., Hodi, F.S., Brahmer, J.R., Gettinger, S.N., Smith, D.C., McDermott, D.F., Powderly, J.D., Carvajal, R.D., Sosman, J.A., Atkins, M.B., Leming, P.D., Spigel, D.R., Antonia, S.J., Horn, L., Drake, C.G., Pardoll, D.M., Chen, L., Sharfman, W.H., Anders, R.A., Taube, J.M., McMiller, T.L., Xu, H., Korman, A.J., Jure-Kunkel, M., Agrawal, S., McDonald, D., Kollia, G.D., Gupta, A., Wigginton, J.M. and Sznol, M. (2012) Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer. The New England Journal of Medicine, 366, 2443-2454.
https://doi.org/10.1056/NEJMoa1200690
|
[34]
|
Tahara-Hanaoka, S., Shibuya, K., Kai, H., Miyamoto, A., Morikawa, Y., Ohkochi, N., Honda, S. and Shibuya, A. (2006) Tumor Rejection by the Poliovirus Receptor Family Ligands of the DNAM-1 (CD226) Receptor. Blood, 107, 1491-1496. https://doi.org/10.1182/blood-2005-04-1684
|
[35]
|
张章, 董光龙, 张赘, 等. CD155在结肠癌组织中的表达及其临床意义[J]. 实用癌症杂志, 2007, 22(5): 441-443.
|
[36]
|
Masson, D., Jarry, A. and Baury, B. (2001) Overexpression of the CD155 Gene in Human Colorectal Carcinoma. Gut, 49, 236-240. https://doi.org/10.1136/gut.49.2.236
|
[37]
|
Huang, Z. (2017) Immune Checkpoint B7-H1 Monoclonal Antibodies for Immunohistochemistry Test in the Diagnosis of Colorectal Cancer. 中国免疫学会. 第十二届全国免疫学学术大会摘要汇编. 中国免疫学会, 2.
|
[38]
|
Bellomo-Brandao, M.A., Andrade, P.D., Costa, S.C., Escanhoela, C.A., Vassallo, J., Porta, G., De Tommaso, A.M. and Hessel, G. (2009) Cytomegalovirus Frequency in Neonatal Intrahepatic Cholestasis Determined by Serology, Histology, Immunohistochemistry and PCR. World Journal of Gastroenterology, 15, 3411-3416.
https://doi.org/10.3748/wjg.15.3411
|
[39]
|
Fionda, C., Abruzzese, M.P., Zingoni, A., Soriani, A., Ricci, B., Molfetta, R., Paolini, R., Santoni, A. and Cippitelli, M. (2015) Nitric Oxide Donors Increase PVR/CD155 DNAM-1 Ligand Expression in Multiple Myeloma Cells: Role of DNA Damage Response Activation. BMC Cancer, 15, 17. https://doi.org/10.1186/s12885-015-1023-5
|
[40]
|
Mancino, R., Aiello, F., Ciuffoletti, E., Di Carlo, E., Cerulli, A. and Nucci, C. (2015) Inferior Retinotomy and Silicone Oil Tamponade for Recurrent Inferior Retinal Detachment and Grade C PVR in Eyes Previously Treated with Pars Plana Vitrectomy or Scleral Buckle. BMC Ophthalmology, 15, 173. https://doi.org/10.1186/s12886-015-0167-z
|